REVOLAX™ Sub-Q with Lidocaine (1 x 1.1 mL) | Across

Short Description

The highest-density structural volumizer in the REVOLAX portfolio, REVOLAX™ Sub-Q with Lidocaine is formulated with 24 mg/mL of cross-linked HA, 0.3% lidocaine, and Across’s signature monophasic regular lattice network. Engineered with the highest elastic modulus ($G’$) and viscosity in the range, it is specifically designed for deep subcutaneous and supraperiosteal placement to provide bone-mimetic structural projection, sharp jawline definition, pronounced chin augmentation, and non-surgical rhinoplasty lasting 12 to 18+ months.

Detailed Description

REVOLAX™ Sub-Q with Lidocaine is an advanced, sterile, non-pyrogenic physiological cross-linked sodium hyaluronate injectable manufactured by Across Co., Ltd. (South Korea). Developed to address severe facial volume depletion and skeletal contour deficiencies, it functions as a firm biological scaffold that reconstructs deep anatomical foundations and provides durable vertical tissue lift.

Formulated with pure, non-animal-derived hyaluronic acid synthesized via bacterial fermentation, REVOLAX Sub-Q utilizes Across’s proprietary Monophasic Regular Dense Lattice Technology. This tightly interconnected, non-particulate 3D matrix provides exceptional cohesive strength and mechanical shear resistance. When placed in deep planes, it resists the heavy compression of dynamic facial musculature (such as the mentalis and masseter muscles) without flattening, spreading laterally, or migrating into adjacent superficial planes. Through rigorous dialysis filtration, residual BDDE is reduced to non-detectable levels, minimizing post-procedure tissue edema and optimizing clinical biocompatibility.

Treatment Areas & Indications

• Lower Face Contouring & Profile Harmonization:

  • Chin augmentation, forward projection, and vertical lengthening (correction of retrognathia and microgenia)

  • Mandibular angle sharpening and crisp linear jawline sculpting

  • Structural effacement of the pre-jowl sulcus

• Midface Bone-Mimetic Volumization:

  • Malar and zygomatic arch deep structural projection

  • Severe midface volume deficit and submalar fat pad deflation

• Non-Surgical Rhinoplasty:

  • Nasal dorsum elevation, bridge straightening, and structural columella support

• Deep Structural Deficits:

  • Deep temporal fossa hollow restoration

  • Age-related deep fat pad atrophy and skeletal resorption support

Key Clinical Advantages

• Maximum Elastic Modulus ($G’$) & Projection: Delivers the highest lifting capacity in the REVOLAX collection, creating sharp, crisp projection that mimics natural bone contours without softening over time.

• Superior Resistance to Lateral Migration: The high cohesion of the dense monophasic lattice ensures that deep supraperiosteal boluses remain anchored at the target injection plane, preventing horizontal spreading.

• Ultra-Low BDDE Residue: Purified through a multi-stage dialysis process that reduces unreacted cross-linker monomers to undetectable trace levels, significantly minimizing post-treatment swelling, erythema, and immune reactivity.

• 10% Volume Advantage (1.1 mL Syringe): Supplied in a 1.1 mL format—providing 10% more product than conventional 1.0 mL industry alternatives for broader clinical coverage.

• Integrated 0.3% Lidocaine: Infused with lidocaine hydrochloride to desensitize deep tissues during needle or cannula extrusion, ensuring high patient comfort throughout high-resistance structural delivery.

• Extended Clinical Durability: Highly resistant to mechanical breakdown and enzymatic degradation by endogenous hyaluronidase, sustaining structural volume for 12 to 18+ months.

Technical Specifications

(South Korea)Regulatory CategoryMedical Device / CE-marked Class III / Prescription Only (Rx)

Professional Advisory: REVOLAX™ Sub-Q with Lidocaine is an authentic high-density medical injectable intended strictly for certified dermatologists, plastic surgeons, maxillofacial surgeons, and credentialed aesthetic injectors trained in deep periosteal delivery and vascular anatomy. Not intended for superficial dermal application or non-clinical consumer use.